IPO Watch: Two gold explorers lead a pack of ASX debuts in January
Link copied to
January is offering investors a feast of gold, tech and biotech IPO offers to dine on, with ASX new arrivals seeking to raise a combined $85.5m of fresh funds for their businesses.
Two-thirds of last year’s IPOs returned a profit of about 42 per cent since their listing on the ASX in 2020, and one-third lagged their listing price.
Strongest performing IPO in 2020 was asset management tech stock Cosol (ASX:COS) up nearly 300 per cent since its listing with a market cap of $103m.
Each of these stocks has risen 235 per cent above its listing price in 2020, which for Desert Metals is even more spectacular as it only listed last month.
Resources and mining stocks supplied half of the ASX IPOs that gained more than 100 per cent last year.
At the other end of the price performance spectrum for 2020 is pay-by-installments stock Zebit (ASX:ZBT), down 40 per cent from its list price.
And medical company Emyria (ASX:EMD), which produces cannabinoid treatments, is lagging 55 per cent from its start point on the ASX in February.
Seven ASX newcomers have a firm listing date for January and include three tech stocks, two health companies, and two metals explorers.
First off the starting blocks is cancer cell detection devices company Truscreen Group (ASX:TRU) which lists on the ASX on Wednesday.
The medical company had a target of $2.5m in its IPO that closed on December 18 at a price of 7c per share.
Copper-cobalt-gold explorer Torrens Mining (ASX:TRN) is next in line to list on the ASX on Thursday to raise $10m at a price of 20c per share.
WA gold projects company Auric Mining (ASX:AWJ) is due to start trading on the ASX at the end of this week and is raising $10m.
The following week of January 11 to 15 sees two ASX IPOs starting with Felix Group (ASX:FLX), a cloud-based services as a solution company on Tuesday.
The company’s business model is to offer a range of procurement business processes that make it easier for service providers to engage with customers.
Felix Group wants to raise $12m to develop its business and its IPO was priced at 36c per share.
At the end of next week, Friday, it is the turn of traffic solutions technology company Acusensus (ASX:ACE) to list on the ASX.
The commercial traffic management company aimed to raise $10m in its IPO priced at $2.25 per share.
In the week of January 18 to 22, two more ASX newcomers list on the exchange starting with biotech company Chimeric Therapeutics (ASX:CHM) on Monday.
The company is developing a cancer cell therapy drug and has the largest IPO for January at $35m priced at 20c per share.
Rounding off the list of January IPOs is Nexion Group (ASX:NNG) which lists on January 20 after an IPO for $8m.
Nexion Group is a data technology security company that offers cloud computing and network services and end-to-end technology solutions.